Synthon Pharmaceuticals, Inc. Company Profile

News Articles [ 28 Associated News Articles listed on BioPortfolio]

Synthon Unveils Another ADC Facility

ADCs are a hot topic in drug development even though only two have been approved so far and one of those withdrawn. Regardless, Roche's (Genentech) T-DM1 is widely expected to gain approval in 2013 an...

Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab

Synthon announced that it has entered into a global license agreement with Amgen Inc. and Watson Pharmaceuticals, Inc. for Synthon’s trastuzumab, being developed as a biosimilar to Herceptin®, whic...

Synthon Unveils ADC Facility as Data Show Promise for First Candidate

Following a wave of recent investment in ADC production, Synthon has opened an ADC manufacturing facility in Nijmegen, Netherlands, to help bring its first preclinical ADC program to clinical trials b...

Amgen, Synthon and Watson Pharmaceuticals in a biosimilar pact

Synthon has entered into a global license agreement with Amgen  and Watson Pharmaceuticals, for Synthon’s trastuzumab, being developed as a biosimilar to Herceptin, which is currently approved for...

Leica Biosystems and Synthon Biopharmaceuticals partner to develop companion diagnostics for cancer

Leica Biosystems and Synthon Biopharmaceuticals, a subsidiary of speciality pharmaceutical company Synthon, have agreed to collaborate on the development and commercialisation of a companion diagnosti...

Watson and Amgen take on Synthon's biosimilar Herceptin

Watson has acquired the licence to Synthon's biosimilar version of Herceptin (trastuzumab) for an undisclosed amount. Watson has in turn contributed the product to its biosimilars collaboration with A...

Synthon chooses Avacta’s Optim 1000 for high throughput formulation studies

Pharmaceutical developers at Synthon have chosen an Optim 1000 high throughput, micro-volume protein analysis system...

Synthon Biopharmaceuticals announces promising results with its antibody-drug conjugate program

Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).

Drugs and Medications [ 5 Associated Drugs and Medications listed on BioPortfolio]

Simvastatin orally disintegrating tablets(simvastatin) [Synthon Pharmaceuticals, Inc.]

SIMVASTATIN ORALLY DISINTEGRATING TABLETS(SIMVASTATIN)

Levocetirizine dihydrochloride [Synthon Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use levocetirizine dihydrochloride tablets safely and effectively. See full prescribing information for levocetirizine dihydrochloride tab...

Bicalutamide [Synthon Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use Bicalutamide Tablets, USP safely and effectively. See full prescribing information for Bicalutamide Tablets, USP. Bicalutamide Tablet...

Tamsulosin hydrochloride [Synthon Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use tamsulosin hydrochloride capsules, USP safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules,...

Amlodipine besylate tablets [Synthon Pharmaceuticals, Inc.]

Amlodipine Besylate Tablets

PubMed Articles [ 44 Associated PubMed Articles listed on BioPortfolio]

The metal-carbonylπ(aryl) interaction as a supramolecular synthon for the stabilisation of transition metal carbonyl crystal structures.

M-carbonyl(lone pair)π(aryl) interactions provide stability to their transition metal crystal structures. This supramolecular synthon usually leads to zero- or one-dimensional aggregation patterns; a...

New strategy to construct fused/bridged/spiro carbocyclic scaffolds based on the design of novel 6-C synthon precursor.

In this article we report a new strategy to build fused/spiro/bridged carbocyclic systems with a novel 6-C synthon from readily available diallyl diacetates through the sequential Pd-catalyzed double...

Silyl glyoxylates. Conception and realization of flexible conjunctive reagents for multicomponent coupling.

This Perspective describes the discovery and development of silyl glyoxylates, a new family of conjunctive reagents for use in multicomponent coupling reactions. The selection of the nucleophilic and...

MMT, Npeoc-protected spermine, a valuable synthon for the solid phase synthesis of oligonucleotide oligospermine conjugates via guanidine linkers.

Solid phase spermine oligomerization via guanidine linkers was achieved using activated thiourea coupling reaction with primary amino group. Disymmetric spermine synthon was efficiently synthesised in...

Copper(ii) carboxylate tetramers formed from an enantiopure ligand containing a π-stacking supramolecular synthon: single-crystal to single-crystal enantioselective ligand exchange.

An enantiopure ligand built from connecting the ππ stacking 1,8-naphthalimide supramolecular synthon with l-asparagine, L(asn)(-), forms tetrameric [Cu(4)(L(asn))(8)(py)(MeOH)]. The methanol ligand,...

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

Synthon Pharmaceuticals, Inc.

Synthon is an independent group of affiliated pharmaceutical companies dedicated to the development, registration, production, marketing and distribution of a wide range of pharmaceutical products. Fo...

Synthon Chiragenics Corporation

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for deca...